Tae H. Lee

Fujian Key Laboratory Of Cognitive Function And Diseases, Fujian Provincial Key Laboratory Of Brain Aging And Neurodegenerative Diseases
Fuzhou, 350122, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 56 publications

Development of a Novel AAV-Mediated microRNA Gene Therapy for Spatial Suppression of BACE1 to Improve Cognitive Function in Alzheimer's Disease Model Mice.

Development of a Novel AAV-Mediated microRNA Gene Therapy for Spatial Suppression of BACE1 to Improve Cognitive Function in Alzheimer's Disease Model Mice.

Journal: Biomolecules

Published: June 18, 2026

A Novel PROTAC Confers a Dual Benefit Against Amyloid and Tau Pathology in Alzheimer's Disease via DAPK1 Degradation.

A Novel PROTAC Confers a Dual Benefit Against Amyloid and Tau Pathology in Alzheimer's Disease via DAPK1 Degradation.

Journal: International journal of biological sciences

Published: January 14, 2026

Selective degradation of DAPK1 via a novel hydrophobic tagging attenuates tau pathology in Alzheimer's disease.

Selective degradation of DAPK1 via a novel hydrophobic tagging attenuates tau pathology in Alzheimer's disease.

Journal: Journal of advanced research

Published: August 09, 2025

Zipper-interacting Protein Kinase Modulates Gene Expression Linked to Synaptic and Neuronal Processes after Traumatic Brain Injury.

Zipper-interacting Protein Kinase Modulates Gene Expression Linked to Synaptic and Neuronal Processes after Traumatic Brain Injury.

Journal: Molecular neurobiology

Published: August 01, 2025

Death-associated protein kinase 1-dependent SENP1 degradation increases tau SUMOylation and leads to cognitive dysfunction in a mouse model for tauopathy.

Death-associated protein kinase 1-dependent SENP1 degradation increases tau SUMOylation and leads to cognitive dysfunction in a mouse model for tauopathy.

Journal: Molecular neurodegeneration

Published: June 23, 2025

Design, synthesis, and biological evaluation of death-associated protein kinase 1 PROTACs.

Design, synthesis, and biological evaluation of death-associated protein kinase 1 PROTACs.

Journal: Bioorganic chemistry

Published: June 21, 2025

Saikosaponin C ameliorates tau-related pathology by modulating oxidative stress and MAPK axis in Alzheimer's disease.

Saikosaponin C ameliorates tau-related pathology by modulating oxidative stress and MAPK axis in Alzheimer's disease.

Journal: Journal of ethnopharmacology

Published: May 08, 2025

Multifaceted role of zipper-interacting protein kinase beyond cell death: Implication of ZIPK dysregulation in neuronal and vascular injuries.

Multifaceted role of zipper-interacting protein kinase beyond cell death: Implication of ZIPK dysregulation in neuronal and vascular injuries.

Journal: Pharmacological research

Published: March 31, 2025

Corrigendum to "Pin1 inhibition reverses the acquired resistance of human hepatocellular carcinoma cells to Regorafenib via the Gli1/Snail/E-cadherin pathway" [Cancer Lett. 444 (2019) 82-93].

Corrigendum to "Pin1 inhibition reverses the acquired resistance of human hepatocellular carcinoma cells to Regorafenib via the Gli1/Snail/E-cadherin pathway" [Cancer Lett. 444 (2019) 82-93].

Journal: Cancer letters

Published: September 27, 2024

Zipper-interacting protein kinase mediates neuronal cell death and cognitive dysfunction in traumatic brain injury via regulating DEDD.

Zipper-interacting protein kinase mediates neuronal cell death and cognitive dysfunction in traumatic brain injury via regulating DEDD.

Journal: Cell death & disease

Published: September 12, 2024

Potential Implications of miRNAs in the Pathogenesis, Diagnosis, and Therapeutics of Alzheimer's Disease.

Potential Implications of miRNAs in the Pathogenesis, Diagnosis, and Therapeutics of Alzheimer's Disease.

Journal: International journal of molecular sciences

Published: October 18, 2023

Death-associated protein kinase 1 as a therapeutic target for Alzheimer's disease.

Death-associated protein kinase 1 as a therapeutic target for Alzheimer's disease.

Journal: Translational neurodegeneration

Published: October 04, 2023

Showing 1-12 of 56

Last Updated: 09/26/2026